This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Johannes Nelke: Patent Activity in Tumor Necrosis Factor Receptor Research
Introduction
Johannes Nelke is an inventor associated with Würzburg, Germany, and Julius-Maximilians-Universität Würzburg. His work includes a patent concerning antibody fusion proteins designed to activate members of the tumor necrosis factor receptor superfamily.
Latest Patents
Nelke is listed on 1 patent: “Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF) Receptor-Activating Antibody Fusion Proteins with FcγR-Independent Agonistic Activity,” also referred to as TRAAFFIAA. The invention describes receptor-activating antibody fusion proteins with agonistic activity that does not depend on Fcγ receptors.
Career Highlights
Nelke’s listed patent connects his inventive work with biomedical research at Julius-Maximilians-Universität Würzburg. The patent focuses on an approach to activating TNF receptor superfamily members.
Collaborations
His listed coworkers include Andreas Beilhack and Juliane Medler.
Conclusion
Johannes Nelke’s patent activity reflects research into antibody fusion proteins and TNF receptor superfamily activation at Julius-Maximilians-Universität Würzburg.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile